Skip to content

Who, what, where and when: tailoring PrEP services to increase uptake

Dr Narukjaporn Thammajaruk at AIDS 2022. Photo©Marcus Rose/IAS

HIV test-and-treat reduces TB incidence in the community

Dr Carina Marquez at AIDS 2022. Photo: Roger Pebody

Minimal antibody response in Imbokodo compels change of course for HIV vaccine research

Dr Avi Kenny at AIDS 2022. Photo ©Steve Forrest/Workers’ Photos/IAS

Biktarvy combination pill may be most effective option for people with HIV and hepatitis B

Dr Anchalee Avihingsanon at AIDS 2022. Photo ©Steve Forrest/Workers’ Photos/IAS

Educating police on harm reduction can help to prevent HIV and fatal overdoses

Dr Javier Cepeda at AIDS 2022. Photo ©Jordi Ruiz Cirera/IAS.

Smart new single-cell assay shines a light on the HIV reservoir

Dr Eli Boritz at AIDS 2022. Photo ©Steve Forrest/Workers’ Photos/IAS

PrEP inequities have worsened in the US over the last decade, both racially and regionally

AIDSVu graph showing the PrEP-to-Need Ratio (PnR) in the US.

Six-country study shows dolutegravir-based treatment is highly effective in children and adolescents

Young people at a Baylor International Pediatric AIDS Initiative Centre in Tanzania. Photo with permission, Baylor College of Medicine Children's Foundation, Tanzania.

Gaps in U=U awareness globally: healthcare providers need to do more to get the message out

Richard Angell and Chamut Kifetew from the Terrence Higgins Trust at AIDS 2022. Photo by Matthew Hodson.